- Home
- KRYS vs APLE Comparison
KRYS vs APLE Comparison
Compare KRYS & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- APLE
- Stock Information
- Founded
- KRYS 2015
- APLE 2007
- Country
- KRYS United States
- APLE United States
- Employees
- KRYS N/A
- APLE N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- APLE Real Estate Investment Trusts
- Sector
- KRYS Health Care
- APLE Real Estate
- Exchange
- KRYS Nasdaq
- APLE Nasdaq
- Market Cap
- KRYS 4.6B
- APLE 3.7B
- IPO Year
- KRYS 2017
- APLE 2015
- Fundamental
- Price
- KRYS $187.96
- APLE $14.77
- Analyst Decision
- KRYS Strong Buy
- APLE Buy
- Analyst Count
- KRYS 7
- APLE 4
- Target Price
- KRYS $210.00
- APLE $17.25
- AVG Volume (30 Days)
- KRYS 245.3K
- APLE 1.7M
- Earning Date
- KRYS 02-19-2025
- APLE 02-24-2025
- Dividend Yield
- KRYS N/A
- APLE 6.84%
- EPS Growth
- KRYS 669.23
- APLE 23.65
- EPS
- KRYS 3.00
- APLE 0.86
- Revenue
- KRYS $290,515,000.00
- APLE $1,410,888,000.00
- Revenue This Year
- KRYS $483.09
- APLE N/A
- Revenue Next Year
- KRYS $57.70
- APLE $2.27
- P/E Ratio
- KRYS $62.62
- APLE $17.20
- Revenue Growth
- KRYS 473.02
- APLE 6.04
- 52 Week Low
- KRYS $109.57
- APLE $13.60
- 52 Week High
- KRYS $219.34
- APLE $16.99
- Technical
- Relative Strength Index (RSI)
- KRYS 73.39
- APLE 36.81
- Support Level
- KRYS $148.00
- APLE $15.16
- Resistance Level
- KRYS $190.00
- APLE $15.44
- Average True Range (ATR)
- KRYS 7.31
- APLE 0.31
- MACD
- KRYS 3.66
- APLE -0.05
- Stochastic Oscillator
- KRYS 93.87
- APLE 5.63
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.